SynthesisHaematologica2024

Improved survival for dose-intensive chemotherapy in primary mediastinal B-cell lymphoma: a systematic review and meta-analysis of 4,068 patients.

Michael R Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.